Nataliia Naumova

Dr. Nataliia Naumova

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2020 in Membranes
Verified
Journal Article
Open access
PDF file
NNNataliia Naumova
Nataliia Naumova
RŠRadek Šachl
Radek Šachl
Mitochondria represent the fundamental system for cellular energy metabolism, by not only supplying energy in the form of ATP, but also by affecting physiology and cell death via the regulation of calcium homeostasis and the activity of Bcl-2 proteins. A lot of research has recently been devoted to understanding the interplay between Bcl-2 proteins, the regulation of these interactions within the cell, and how these interactions lead to the changes in calcium homeostasis. However, the role of Bcl-2 proteins in the mediation of mitochondrial calcium homeostasis, and therefore the induction of cell death pathways, remain underestimated and are still not well understood. In this review, we first summarize our knowledge about calcium transport systems in mitochondria, which, when miss-regulated, can induce necrosis. We continue by reviewing and analyzing the functions of Bcl-2 proteins in apoptosis. Finally, we link these two regulatory mechanisms together, exploring the interactions between the mitochondrial Ca2+ transport systems and Bcl-2 proteins, both capable of inducing cell death, with the potential to determine the cell death pathway—either the apoptotic or the necrotic one.

20 February 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
FTFrancesco Tona
Francesco Tona
GCGiovanni Civieri
Giovanni Civieri
MVMarta Vadori
Marta Vadori
GMGiulia Masiero
Giulia Masiero
Laura IopLaura Iop
Laura Iop
SISabino Iliceto
Sabino Iliceto
Background: The left ventricular remodeling (LVR) process has limited the effectiveness of therapies after myocardial infarction. The relationship between autoantibodies activating AT1R‐AAs (angiotensin II receptor type 1‐AAs) and ETAR‐AAs (autoantibodies activating endothelin‐1 receptor type A) with myocardial infarction has been described. Among patients with ST‐segment–elevation myocardial infarction, we investigated the relationship between these autoantibodies with LVR and subsequent major adverse cardiac events. Methods and Results: In this prospective observational study, we included 131 patients with ST‐segment–elevation myocardial infarction (61±11 years of age, 112 men) treated with primary percutaneous coronary intervention. Within 48 hours of admission, 2‐dimensional transthoracic echocardiography was performed, and blood samples were obtained. The seropositive threshold for AT1R‐AAs and ETAR‐AAs was >10 U/mL. Patients were followed up at 6 months, when repeat transthoracic echocardiography was performed. The primary end points were LVR, defined as a 20% increase in left ventricular end‐diastolic volume index, and major adverse cardiac event occurrence at follow‐up, defined as cardiac death, nonfatal re‐myocardial infarction, and hospitalization for heart failure. Forty‐one (31%) patients experienced LVR. The prevalence of AT1R‐AAs and ETAR‐AAs seropositivity was higher in patients with versus without LVR (39% versus 11%, P <0.001 and 37% versus 12%, P =0.001, respectively). In multivariable analysis, AT1R‐AAs seropositivity was significantly associated with LVR (odds ratio [OR], 4.66; P =0.002) and represented a risk factor for subsequent major adverse cardiac events (OR, 19.6; P =0.002). Conclusions: AT1R‐AAs and ETAR‐AAs are associated with LVR in patients with ST‐segment–elevation myocardial infarction. AT1R‐AAs are also significantly associated with recurrent major adverse cardiac events. These initial observations may set the stage for a better pathophysiological understanding of the mechanisms contributing to LVR and ST‐segment–elevation myocardial infarction prognosis.

1 July 2019 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
IZIhor Zadorozhnyi
Ihor Zadorozhnyi
HHHanna Hlukhova
Hanna Hlukhova
YKYurii Kutovyi
Yurii Kutovyi
VHVolodymyr Handziuk
Volodymyr Handziuk
NNNataliia Naumova
Nataliia Naumova
SVS. A. Vitusevich
S. A. Vitusevich

1 January 2019 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
NNNataliia Naumova
Nataliia Naumova
HHHanna Hlukhova
Hanna Hlukhova
ABAlexander Barannik
Alexander Barannik
AGAlexey Gubin
Alexey Gubin
IPIrina Protsenko
Irina Protsenko
SVS. A. Vitusevich
S. A. Vitusevich

15 April 2010
Verified
Journal Article
Closed access
NNNataliia Naumova
Nataliia Naumova
LBL H Babich
L H Babich
SSS H Shlykov
S H Shlykov

1 May 2018
Verified
Conference Paper
Closed access
NNNataliia Naumova
Nataliia Naumova
HHHanna Hlukhova
Hanna Hlukhova
SVS. A. Vitusevich
S. A. Vitusevich
ABAlexander Barannik
Alexander Barannik
AGAlexey Gubin
Alexey Gubin
NCNikolay Cherpak
Nikolay Cherpak